Autopsy report · NCT05814016
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
Cause of deathFunding or business
“Business decision unrelated to patient safety.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 4 months before it stopped.
- 41 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Takeda
- Sponsor type
- Industry
- Conditions
- Sleep Apnea
- Interventions
- Danavorexton; Placebo
- Participants
- 41
- Sites
- 19
- Countries
- United States
Trials that died the same way
- Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment
“Business decision, not related to safety” - Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
“Based on a business decision unrelated to any safety concerns.” - A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
“business decision, not safety reasons.” - Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
“Business Decision; No Safety Or Efficacy Concerns. (See below)” - Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
“study was stopped for business/administrative reasons and not for patient safety concerns”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.